Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin secretion refers to the process by which pancreatic beta cells release insulin in response to stimuli, primarily elevated blood glucose. This involves glucose uptake, ATP production, K_ATP channel closure, membrane depolarization, calcium influx, and exocytosis of insulin-containing granules. It is tightly regulated by nutrients, hormones, and transcription factors, and its dysfunction leads to diseases like diabetes.
Various. Sulfonylureas close K_ATP channels. GLP-1 receptor agonists increase cAMP. DPP-4 inhibitors increase endogenous GLP-1 levels. Glinides also close K_ATP channels.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Secretion (Pancreatic Beta Cell Stimulation) (N/A).